Caribou Biosciences Competitors and Similar CompaniesClear all

Caribou Biosciences's competitors and similar companies include Biocytogen, Editas Medicine, Creyon Bio and Applied Biological Materials.

	Caribou Biosciences Caribou Biosciences is a leading biotechnology company in genome engineering. We develop technology-based solutions for cellular.	Biocytogen Biocytogen is a biotechnology company that specializes in gene-modified animal model production.	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.	Creyon Bio Creyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs).	Applied Biological Materials Applied Biological Materials is a company that provides research reagents.
Founding Date	Founding Date 2011	Founding Date 2009	Founding Date 2013	Founding Date 2019	Founding Date 2004
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare bioengineering biotech genetics	Tags Technology bioengineering biotech genetics medtech	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Berkeley, US HQ	Locations Wakefield, US HQ Beijing, CN Nantong, CN	Locations Cambridge, US HQ Boulder, US Cambridge, US	Locations Carlsbad, US HQ Bengaluru, IN Durham, US	Locations Richmond, CA HQ Richmond, CA Ferndale, US
Employees	Employees 1631% increase	Employees 1404% decrease	Employees 20816% increase	Employees 62	Employees 632% increase
Valuation ($)	Valuation ($) 178.9 m	Valuation ($) N/A	Valuation ($) 281.2 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $34.5m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $78.1m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($102.1m) (FY, 2023)	Net income N/A	Net income ($153.2m) (FY, 2023)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 142m (about 4 years ago)	Latest funding round N/A	Latest funding round $ 40m (over 2 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 159.5m	Total funding raised $ 284.3m	Total funding raised $ 210m	Total funding raised $ 40m	Total funding raised N/A